Sports Medicine Devices – Market Insights – United States

The US sports medicine device market had been significantly impacted by treatment deferrals and the elective nature of sports medicine procedures following the COVID-19 pandemic; however, by 2022, the market had largely recovered and is poised to resume modest growth over the forecast period. Although a growing trend toward arthroscopic techniques and premium products such as biocomposite suture anchors and all-inside meniscus repair devices are driving increasing aggregate ASPs, the ongoing transition away from hospitals and into ASCs as the site of service for many sports medicine procedures is dampening the pace of ASP growth due to pricing pressures among the latter facilities.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for sports medicine devices in the US from 2019 through 2032.

Following the COVID-19 outbreak, the backlog of procedures deferred during the pandemic has nearly been completely recovered.

What extent of procedures were delayed or lost in the different sports medicine device market segments due to the COVID-19 pandemic?

Which market impacts and adaptations are here to stay?

How have elective procedures, such as those which constitute the majority of sports medicine procedures, recovered?

The sports medicine device market is growing due to the adoption of premium-priced technology.

What new product coverages have been added to the report to reflect the dynamics of this market?

What product innovations are competitors pursuing in order to capitalize on the growing sports medicine device segments?

Which types of sports injuries are growing the fastest, and how does that translate to market size?

The leading manufacturers are using partnerships with other organizations to extend procedural offerings.

How do partnerships between manufacturers and tissue banks affect market share?

What procedural solutions are afforded by close partnerships between device and tissue collaborations?

Which products from smaller organizations are growing because of distribution partnerships with large MNCs?

Alternative treatment options may have limiting effects on the sports medicine device market.

Which market segments are under the most pressure from alternative treatment options that compete against device-based solutions?

To what extent will alternative treatments affect procedure volumes and units sold?

Sports medicine procedures are increasingly occurring in ASCs.

To what extent will different pricing dynamics in ASCs affect aggregate ASPs for sports medicine devices across the forecast period?

What strategies are competitors within the sports medicine device market employing to increase penetration in the growing ASC space?

How will procedural dynamics across ASCs and hospitals affect sports medicine device sales trends?

Table of contents